Asthma
Showing NaN - NaN of 183
Asthma Trial in Hamilton, London (Aerobika OPEP device)
Not yet recruiting
- Asthma
- Aerobika OPEP device
-
Hamilton, Ontario, Canada
- +1 more
Nov 15, 2023
Inflammatory and Physiological Profiles of Healthy and Diseased
Not yet recruiting
- COPD
- +2 more
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Nov 16, 2023
The Living With a Long-Term Condition Study
Recruiting
- Asthma
- +44 more
- Living with LTC Questionnaire
-
London, United KingdomKing's College London
Oct 10, 2023
Non-tailpipe Emissions From Traffic on the Asthmatic Airway
Active, not recruiting
- Asthma
- Exercise exposure
-
London, United KingdomQueen Mary University London
Apr 28, 2023
Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)
Not yet recruiting
- Asthma
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Apr 26, 2023
Asthma Trial in Worldwide (Benralizumab, Placebo)
Recruiting
- Asthma
- Benralizumab
- Placebo
-
Los Angeles, California
- +35 more
Feb 1, 2023
Asthma Trial in Canada (Vitamin D, Placebo)
Recruiting
- Asthma
- Vitamin D
- Placebo
-
Vancouver, British Columbia, Canada
- +8 more
Jan 30, 2023
Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)
Recruiting
- Asthma
- BGF MDI 320/28.8/9.6 μg
- +3 more
-
Birmingham, Alabama
- +423 more
Jan 18, 2023
Asthma Trial in Worldwide (Tezepelumab)
Recruiting
- Asthma
- Tezepelumab
-
Newport Beach, California
- +102 more
Jan 11, 2023
Asthma Trial in London, Manchester (Human beta common receptor antagonist mAb, Placebo)
Recruiting
- Asthma
- Human beta common receptor antagonist monoclonal antibody
- Placebo
-
Berlin, Germany
- +2 more
Dec 21, 2022
Asthma Trial in Worldwide (MEDI3506, Placebo)
Active, not recruiting
- Asthma
- MEDI3506
- Placebo
-
Bakersfield, California
- +64 more
Dec 19, 2022
Associated Burden of Related Conditions in Alopecia Areata
Completed
- Alopecia Areata
- +35 more
- Exposure of interest (studies 2 & 3).
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Observational Study of Obstructive Lung Disease (NOVELTY)
Active, not recruiting
- Asthma
- +2 more
- Blood draw
- +3 more
-
Loma Linda, California
- +302 more
Nov 22, 2022
Asthma Trial in London (My Asthma in School)
Completed
- Asthma
- My Asthma in School
-
London, United KingdomQueen Mary University of London
Nov 9, 2022
Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)
Enrolling by invitation
- Autism Spectrum Disorder
- +6 more
- SRS 2, CBCL, BRIEF-P
-
Penrith, New South Wales, Australia
- +57 more
Sep 18, 2022
Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)
Active, not recruiting
- Asthma
- Severe Eosinophilic Asthma
- Symbicort®
- +2 more
-
Brest Cedex, France
- +22 more
Aug 24, 2022
Asthma Trial in United Kingdom (AZD4604 for inhalation via DPI, Placebo for AZD4604 for inhalation via DPI, AZD4604 for IV
Recruiting
- Asthma
- AZD4604 for inhalation via DPI
- +3 more
-
Belfast, United Kingdom
- +3 more
Aug 10, 2022
Pulmonary Epithelium, Immunology and Development of Asthma:
Recruiting
- Asthma
- Wheezing
-
London, United KingdomRoyal Brompton and Harefield NHS Foundation Trust
May 20, 2022